GSK2256098 Uses, Dosage, Side Effects and more

GSK2256098 is under investigation in clinical trial NCT02523014 (Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas).

Trade Name GSK2256098
Generic GSK2256098
Type
Formula C20H23ClN6O2
Weight Average: 414.89
Monoisotopic: 414.1571017
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share